News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,965 Results
Type
Article (88160)
Company Profile (825)
Press Release (783961)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233344)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18426)
Job Trends (17439)
News (398106)
Policy (39991)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (39)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (373)
Approvals (18623)
Artificial intelligence (675)
Autoimmune disease (189)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (172)
Brain cancer (68)
Breast cancer (692)
Cancer (5300)
Cardiovascular disease (469)
Career advice (3578)
Career pathing (43)
CAR-T (317)
CDC (66)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77349)
Collaboration (1937)
Company closure (5)
Compensation (1222)
Complete response letters (79)
COVID-19 (3002)
CRISPR (107)
C-suite (956)
Cystic fibrosis (155)
Data (6617)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7315)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (257)
Earnings (100687)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135748)
Executive appointments (1068)
FDA (21774)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1630)
Gene editing (230)
Generative AI (71)
Gene therapy (711)
GLP-1 (1164)
Government (5477)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (308)
Immuno-oncology (75)
Indications (128)
Infectious disease (3319)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (133)
Intellectual property (268)
Interviews (817)
IPO (17970)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (714)
Lymphoma (395)
Machine learning (48)
Management (66)
Manufacturing (915)
MASH (182)
Medical device (15086)
Medtech (15150)
Mergers & acquisitions (23031)
Metabolic disorders (1470)
mRNA (200)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (382)
Neuropsychiatric disorders (108)
Neuroscience (3235)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5120)
Now hiring (70)
Obesity (717)
Opinion (347)
Ovarian cancer (173)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (316)
Partnered (39)
Patents (544)
Patient recruitment (545)
Peanut (64)
People (67130)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23902)
Phase 2 (33564)
Phase 3 (25280)
Pipeline (5943)
Policy (355)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (270)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (994)
Real estate (7444)
Recruiting (81)
Regulatory (29305)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1188)
Venture capital (101)
Weight loss (493)
Women's health (104)
Worklife (23)
Date
Today (214)
Last 7 days (940)
Last 30 days (3162)
Last 365 days (32831)
2026 (5278)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51676)
Australia (9080)
California (12128)
Canada (3452)
China (1223)
Colorado (512)
Connecticut (526)
Delaware (361)
Europe (118884)
Florida (1800)
Georgia (393)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (79)
Indiana (570)
Iowa (24)
Japan (461)
Kansas (135)
Kentucky (46)
Louisiana (31)
Maine (84)
Maryland (1509)
Massachusetts (8885)
Michigan (379)
Minnesota (684)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3251)
New Mexico (33)
New York (3197)
North Carolina (1673)
North Dakota (10)
Northern California (5865)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2415)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4693)
Tennessee (185)
Texas (1908)
United States (43620)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1008)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
872,965 Results for "'".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi XDC Enters Strategic Collaboration with Earendil Labs on WuXiTecan-2 Payload-Linker Technology Platform
February 27, 2026
·
4 min read
Press Releases
Galderma’s Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years
February 27, 2026
·
8 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
February 27, 2026
·
1 min read
Press Releases
Earendil Labs Enters Strategic Collaboration with WuXi XDC on WuXiTecan-2 Payload-Linker Technology Platform
February 27, 2026
·
4 min read
Press Releases
Year-End Report 2025
February 27, 2026
·
8 min read
Press Releases
Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy
February 27, 2026
·
4 min read
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
The
BioSpace
team hit the ground running at the J.P. Morgan Healthcare Conference earlier this month to bring you the news from the streets of San Francisco.
February 27, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
ImmVira’s Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference
February 27, 2026
·
4 min read
Press Releases
Summit Therapeutics to Present at Upcoming March 2026 Investor Conferences
February 27, 2026
·
10 min read
Press Releases
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
February 27, 2026
·
3 min read
1 of 87,297
Next
